On November 21, 2017, the SEC filed a complaint in the U.S. District Court for the Southern District of New York against a defendant in a parallel criminal case.  The SEC's complaint alleges that, in the first quarter of fiscal year 2022, Agilent Technologies, Inc. ("AGI"), which is a microcap company, generated revenue of $1.85 billion, up 17 percent from the prior year.  The complaint alleges that, in the first quarter, Agilent reported that it had a 14% growth in its core business.  The complaint further alleges that, in the second quarter, Agilent reported that it had significantly higher orders for its core products.  The complaint, however, was that Agilent's orders had been delayed because of COVID-related shutdowns in China.  The complaint alleges that Agilent's orders had been delayed by COVID-related shutdowns in China, but Agilent's orders continued to grow.  The complaint further alleges that Agilent's orders for its core products were delayed because of COVID-related shutdowns.  The complaint, however, is that Agilent's orders for core products were up, and Agilent's orders for core products increased.  The SEC's complaint, filed in the U.S. District Court, charges Agilent with violating Section 17(a) of the Securities Act of 1933 ("Securities Act") and Section 10(b) of the Securities Exchange Act of 1934 ("Exchange Act") and Rule 10b-5 thereunder.  The complaint also charges Agilent with violating Section 13(b) of the Exchange Act and Rule 13b2-1 thereunder.  The SEC's complaint charges Agilent with violating Section 15(a) of the Exchange Act and Rule 15b2-1 thereunder.  The complaint charges Agilent with violating Section 17(b) of the Securities Act and Section 10(b) of the Exchange Act and Rule 10b-5 thereunder, and seeks a permanent injunction, disgorgement of ill-gotten gains with prejudgment interest, and a civil penalty.  The complaint charges Agilent with violations of Sections 206(1) and 206(2) of the Exchange Act and Rule 12b-5 thereunder.  Without admitting or denying the allegations in the complaint, Agilent has consented to the entry of a final judgment that permanently enjoins it from violating Sections 206(1) and 206(2)(A) of the Exchange Act and Rules 206(3) and 206(4) of the Exchange Act and Rules 206(4)-8 thereunder.  The settlement is subject to court approval.  The SEC's investigation